NEW YORK & ST. LOUIS & SINGAPORE--(BUSINESS WIRE)--Varro Holdings, Inc. (“Varro”), an emerging leader in products that disrupt the transmission of infectious disease, today announced it has entered into an agreement with Vitalik Buterin to receive 20 million USDC (equal to $20 million) in non-dilutive financial support for the development of its novel pathogen detection technology, and to make the technology available via open source.

纽约、圣路易斯和新加坡——（商业新闻短讯）——Varro Holdings，Inc.（“Varro”）是一家新兴的破坏传染病传播产品的领导者，今天宣布，它已与Vitalik Buterin达成协议，将获得2000万美元（相当于2000万美元）的非稀释性资金支持，用于开发其新型病原体检测技术，并通过开源提供该技术。

The funds will be provided via Buterin’s scientific finance and direct donation initiative, Kanro..

资金将通过巴特林的科学金融和直接捐赠计划Kanro提供。。

“Our tech platform is unique for its ability to detect very low amounts of virus and other pathogens quickly, effectively, and at low cost,” commented Tom Cirrito, PhD, Chairman and CEO of Varro. “Our partnership with Kanro and our open-sourcing of the technology has the potential to transform global public health by changing the face of infectious disease management and enabling innovation.

Varro董事长兼首席执行官Tom Cirrito博士评论道：“我们的技术平台具有独特的能力，可以快速，有效且低成本地检测极少量的病毒和其他病原体。”。。

We are proud to share Vitalik’s vision of decentralized healthcare and pandemic preparedness.”.

我们很自豪地分享维塔利克关于分散医疗保健和大流行防范的愿景。”。

Vitalik Buterin said, “I’m pleased to support a free and open-source hardware (FOSH) business that will both develop crucial tools for preventing the next pandemic, as well as pioneer a new paradigm of free and open-source hardware development that can enable widely distributed access to tools for personal health and beyond.

维塔利克·巴特林（VitalikButerin）说：“我很高兴支持一项免费开源硬件（FOSH）业务，该业务将开发预防下一次大流行的关键工具，并开创一种免费开源硬件开发的新范例，使人们能够广泛访问个人健康等工具。

A d/acc future is one where everyone can verify that the air they breathe is clean and free from airborne pathogens.'.

d/acc的未来是每个人都可以验证他们呼吸的空气是干净的，没有空气传播的病原体。”。

Varro is commercializing breath-based diagnostic devices, indoor air quality monitors, and micro-immunoelectrode biosensors (MIEs) that detect pathogens in seconds in a variety of settings. Initial target users of the technology include senior living centers, primary care clinics, medical facilities, offices, government and military facilities, and schools.

Varro正在将基于呼吸的诊断设备、室内空气质量监测器和微型免疫电极生物传感器（MIEs）商业化，这些传感器可以在各种环境中在几秒钟内检测病原体。该技术的最初目标用户包括老年生活中心、初级保健诊所、医疗设施、办公室、政府和军事设施以及学校。

The company is committed to demonstrating the advantages of the open-source business model in biotech and diagnostics. Toward that end, the company is establishing an open-source community around the technology..

该公司致力于展示开源商业模式在生物技术和诊断领域的优势。为此，该公司正在围绕这项技术建立一个开源社区。。

The MIE platform is exclusively licensed from Washington University in St. Louis, where it was developed as a collaborative effort between John Cirrito, PhD, a professor of neurology, and Carla Yuede, PhD, a professor of psychiatry, both at the School of Medicine, and Rajan Chakrabarty, PhD at the university’s McKelvey School of Engineering.

MIE平台由圣路易斯华盛顿大学独家授权，该平台是由神经病学教授John Cirrito博士和医学院精神病学教授Carla Yuede博士以及该大学麦凯维工程学院Rajan Chakrabarty博士合作开发的。

The National Institutes of Health, through its RADx program, and FluLab, a private foundation, have also provided grants and support..

美国国立卫生研究院（National Institutes of Health）通过其RADx计划和私人基金会FluLab也提供了赠款和支持。。

About Varro

关于瓦罗

Varro Holdings, Inc. (Varro) is an innovative health-tech company developing products to disrupt the transmission of infectious disease and improve human health. Founded in 2020 as Y2X Life Sciences, the company’s vision is to ensure and enable healthy environments and to prevent future pandemics and disease outbreaks.

Varro Holdings，Inc.（Varro）是一家创新的健康技术公司，开发产品以破坏传染病的传播并改善人类健康。该公司成立于2020年，名为Y2X生命科学，其愿景是确保和实现健康的环境，并防止未来的流行病和疾病爆发。

Marcus Terentius Varro (116-27 BC) was an ancient Roman scholar whose work anticipated the sciences of microbiology and epidemiology..

马库斯·特伦提乌斯·瓦罗（公元前116-27年）是一位古罗马学者，他的工作预见了微生物学和流行病学的科学。。

For more information, visit varrobio.com and connect with the company on LinkedIn.

有关更多信息，请访问varrobio.com并通过LinkedIn与公司联系。

About Vitalik Buterin

关于维塔利克·巴特林

Vitalik Buterin is co-founder of Ethereum. He supports free and open-source biosecurity, pandemic prevention and indoor air quality programs both directly and via his scientific investment and direct gifting funds Balvi and Kanro, which have to date distributed over $400 million worldwide, with a focus on low- and lower-middle-income countries..

维塔利克·巴特林是以太坊的联合创始人。他直接或通过他的科学投资和直接捐赠基金Balvi和Kanro支持免费和开源的生物安全、大流行预防和室内空气质量计划，迄今为止，这些基金已在全球范围内分发了4亿多美元，重点关注中低收入国家。。